Filing Details

Accession Number:
0000899243-18-016599
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-14 16:08:41
Reporting Period:
2018-06-13
Accepted Time:
2018-06-14 16:08:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631650 Aimmune Therapeutics Inc. AIMT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197350 Eric Bjerkholt Aimmune Therapeutics, Inc.
8000 Marina Boulevard, Suite 300
Brisbane CA 94005-1884
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2018-06-13 1,600 $30.41 19,485 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The transaction was executed in multiple trades in prices ranging from $30.35 to $30.4292, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  2. Includes shares represented by restricted stock units ("RSUs") and will be settled in common stock upon vesting over a specified time, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
  3. Includes 385 shares acquired on May 15, 2018 pursuant to Issuer's employee stock purchase plan.